Exposure-Response–Based Multiattribute Clinical Utility Score Framework to Facilitate Optimal Dose Selection for Oncology Drugs The Oncology Grand Rounds series is designed to place original reports ...

Objectives Chorea, characterised by involuntary, irregular movements, is a rare neurological manifestation of antiphospholipid syndrome (APS). The specific clinical features remain unclear. This study ...

Primary central nervous system (CNS) vasculitis is a rare, frequently misdiagnosed condition that affects the brain and ...

Coarctation of the aorta is a congenital disease involving the cardiovascular system. The presentation can range from being ...

Overdiagnosis occurs when patients are diagnosed with a disease that would otherwise never have affected the quality or duration of their lives. This often happens unintentionally through well-meaning ...

The programme consists of clinical and practice modules with real life application ... Assessments include portfolio assessments, case presentations, critical evaluation of care, targeted structured ...

A critical review of the limitations posed by current preclinical animal models of Alzheimer's disease and of the oversimplistic assumptions proposed by the amyloid cascade hypothesis (ACH).

It’s very easy to use coupons in Case Opening Simulator 2. In fact, the process is identical on mobile, console, and PC versions of Roblox. Here’s what you need to do: How Do You Get More Case ...

Sept. 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced two presentations at the 2024 American College of Clinical Pharmacology (ACCP) Annual Meeting in ...

We also assess each tool against its use-case. Some want a lightweight reader, others need one packed with plenty of other PDF utilities for professional use - so we look at how well the free PDF ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The presentations will feature new and updated clinical data on CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy, which is being evaluated in multiple ongoing clini ...